Design, Synthesis, Cytotoxicity Assessment, and Molecular Docking of Novel Triazolopyrimidines as Potent Cyclin‐Dependent Kinase 4 Inhibitors

Documenti analoghi

• Synthesis of Pyrido[2,3‐d]Azolopyrimidinones: Design and Epidermal Growth Factor Receptor‐Targeted Molecular Docking Toward Novel Anticancer Leads
  di: Sobhi M. Gomha, et al.
  Pubblicazione: (2025)
• Insights on Regioselective Synthesis of Fused Thiazoles: Density Functional Theory Calculations, Local Reactivity Indices, and Molecular Electrostatic Potential Analysis
  di: Ghaferah H. Al‐Hazmi, et al.
  Pubblicazione: (2025)
• Design, Synthesis, Bioevaluation, and Bioinformatics Study of 5‐Benzylidene Hydantoin Derivatives as Novel Tyrosine Kinase Inhibitors
  di: Muhammad Naufal, et al.
  Pubblicazione: (2025)
• Design and Synthesis of Polyheterocyclic Compounds Containing Pyrazolopyridopyrimidine Nucleus with Antimicrobial Activities
  di: Farag A. El‐Essawy, et al.
  Pubblicazione: (2024)
• Salen‐Type Copper(II) Complexes: Synthesis, Characterization, Computational Studies, Molecular Docking, Anticancer Potential, and Pharmacokinetic Prediction
  di: Abdellatif A. Helaly, et al.
  Pubblicazione: (2025)